FD
Delie Salmon, Florence
Affiliation entities
Research groups
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer? | Heliyon | 2023 | 65 | 19 | |||
Atorvastatin-loaded spray-dried PLGA microparticles for local prevention of intimal hyperplasia: Drug release rate optimization and activity on synthetic vascular smooth muscle cells | Journal of drug delivery science and technology | 2023 | 233 | 99 | |||
Antibiofilm Synergistic Activity of Streptomycin in Combination with Thymol-Loaded Poly (Lactic-co-glycolic Acid) Nanoparticles against Klebsiella pneumoniae Isolates | Evidence-based complementary and alternative medicine | 2022 | 162 | 84 | |||
Pharmacological prevention of intimal hyperplasia: A state-of-the-art review | Pharmacology & therapeutics | 2022 | 98 | 1 | |||
Bioadhesive Perivascular Microparticle-Gel Drug Delivery System for Intimal Hyperplasia Prevention: In Vitro Evaluation and Preliminary Biocompatibility Assessment | Gels | 2022 | 109 | 53 | |||
Bioadhesive Hyaluronic Acid/Dopamine Hydrogels for Vascular Applications Prepared by Initiator-Free Crosslinking | International journal of molecular sciences | 2022 | 191 | 143 | |||
Thymol and Piperine-Loaded Poly(D,L-lactic-co-glycolic acid) Nanoparticles Modulate Inflammatory Mediators and Apoptosis in Murine Macrophages | Planta medica international open | 2021 | 174 | 71 | |||
Antitumor Effect of 5-Fluorouracil-Loaded Liposomes Containing n-3 Polyunsaturated Fatty Acids in Two Different Colorectal Cancer Cell Lines | AAPS PharmSciTech | 2021 | 253 | 86 | |||
Bioguided identification of pentacyclic triterpenoids as anti-inflammatory bioactive constituents of Ocimum gratissimum extract | Journal of Ethnopharmacology | 2021 | 239 | 549 | |||
Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles | European Journal of Pharmaceutics and Biopharmaceutics | 2020 | 272 | 1 | |||
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment | Pharmaceutics | 2020 | 320 | 224 | |||
Cytotoxicity of a new tirucallane derivative isolated from Stereospermum acuminatissimum K. Schum stem bark | Natural Product Research | 2020 | 299 | 1 | |||
Antiproliferative activity of a new xanthone derivative from leaves of Garcinia nobilis Engl | Natural Product Research | 2020 | 202 | 0 | |||
Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study | European Journal of Pharmaceutics and Biopharmaceutics | 2019 | 442 | 384 | |||
In Michael Moeller's spirit | European Journal of Pharmaceutics and Biopharmaceutics | 2019 | 241 | 0 | |||
Malignant ascites: a source of therapeutic protein against ovarian cancer? | Oncotarget | 2019 | 445 | 147 | |||
Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight | Journal of Controlled Release | 2018 | 387 | 0 | |||
Evaluating intimal hyperplasia under clinical conditions | Interactive Cardiovascular and Thoracic Surgery | 2018 | 390 | 2 | |||
Design and characterization of a perivascular PLGA coated PET mesh sustaining the release of atorvastatin for the prevention of intimal hyperplasia | International Journal of Pharmaceutics | 2018 | 356 | 2 | |||
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation | International Journal of Pharmaceutics | 2018 | 524 | 486 | |||
Functionalized PLA polymers to control loading and/or release properties of drug-loaded nanoparticles | International Journal of Pharmaceutics | 2017 | 409 | 1 | |||
Circulating GRP78 antibodies from ovarian cancer patients: a promising tool for cancer cell targeting drug delivery system? | Oncotarget | 2017 | 563 | 191 | |||
Perivascular medical devices and drug delivery systems: Making the right choices | Biomaterials | 2017 | 1 086 | 666 | |||
Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia | Journal of controlled release | 2016 | 687 | 94 | |||
Role of PAR-4 in ovarian cancer | Oncotarget | 2015 | 556 | 221 | |||
In ovo method for evaluating the effect of nutritional therapies on tumor development, growth and vascularization | Clinical nutrition experimental | 2015 | 575 | 747 | |||
Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram | Journal of Pharmaceutical Sciences | 2014 | 460 | 1 | |||
Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells | Oncoscience | 2014 | 635 | 238 | |||
New high throughput screening method for drug release measurements | European Journal of Pharmaceutics and Biopharmaceutics | 2013 | 439 | 0 | |||
GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78 | Targeted oncology | 2013 | 650 | 279 | |||
Atorvastatin-Loaded Hydrogel Affects the Smooth Muscle Cells of Human Veins | The Journal of pharmacology and experimental therapeutics | 2013 | 623 | 4 | |||
Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivatives | Carbohydrate Polymers | 2012 | 410 | 0 | |||
Pharmaceutical technology at the service of targeted drug delivery | Chimia | 2012 | 427 | 0 | |||
Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer? | Biochimie | 2012 | 597 | 0 | |||
GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach | Journal of oncology | 2012 | 584 | 0 | |||
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice | Journal of controlled release | 2010 | 619 | 3 | |||
Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicity | International Journal of Pharmaceutics | 2010 | 357 | 1 | |||
In vitro blood brain barrier models as a screening tool for colloidal drug delivery systems and other nanosystems | International journal of biomedical nanoscience and nanotechnology | 2010 | 1 084 | 1 037 | |||
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer | Journal of Drug Targeting | 2009 | 396 | 0 | |||
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases | European journal of pharmaceutics and biopharmaceutics | 2009 | 613 | 0 | |||
Potential use of biodegradable nanoparticles for the photodynamic therapy of eye diseases | Archivos de la Sociedad Espanola de Oftalmologia (English Edition) | 2009 | 332 | 92 | |||
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size | European journal of pharmaceutical sciences | 2009 | 609 | 0 | |||
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model | Nanomedicine | 2009 | 597 | 0 | |||
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity | Journal of Drug Targeting | 2009 | 357 | 1 | |||
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells | European journal of pharmaceutical sciences | 2009 | 545 | 0 | |||
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells | European Journal of Pharmaceutics and Biopharmaceutics | 2008 | 444 | 1 | |||
In vivo photodynamic activity of photosensitizer-loaded nanoparticles : formulation properties, administration parameters and biological issues involved in PDT outcome | European journal of pharmaceutics and biopharmaceutics | 2008 | 621 | 1 | |||
Nanoparticles for drug delivery : the need for precision in reporting particle size parameters | European journal of pharmaceutics and biopharmaceutics | 2008 | 594 | 2 | |||
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles | International journal of pharmaceutics | 2007 | 576 | 0 | |||
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation | International journal of pharmaceutics | 2007 | 637 | 7 | |||
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems | Advanced drug delivery reviews | 2007 | 616 | 2 | |||
Nanoparticles for photodynamic therapy of cancer | Nanomaterials for Cancer Therapy | 2006 | 30 | 0 | |||
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer | International journal of pharmaceutics | 2006 | 501 | 1 | |||
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs | Molecules | 2005 | 389 | 1 | |||
Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the Eye | Chimia | 2005 | 405 | 0 | |||
Particulate Systems for Oral Drug Delivery | Microencapsulation : methods and industrial applications | 2005 | 34 | 0 | |||
The use of drug-loaded nanoparticles in cancer chemotherapy | Microencapsulation : Methods and Industrial Applications | 2005 | 31 | 0 | |||
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos | International journal of pharmaceutics | 2004 | 453 | 1 | |||
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles | Investigative Ophthalmology & Visual Science | 2003 | 409 | 96 | |||
Fluorescence correlation spectroscopy for the characterisation of drug delivery systems | Biological chemistry | 2001 | 459 | 0 | |||
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles | International journal of pharmaceutics | 2001 | 492 | 1 | |||
Application of fluorescence correlation spectroscopy for the characterisation of drug delivery systems | CRS proceedings | 1999 | 23 | 25 | |||
Evaluation of nano- and microparticle uptake by the gastrointestinal tract | Advanced drug delivery reviews | 1998 | 399 | 0 | |||
Preface | Advanced drug delivery reviews | 1998 | 344 | 0 | |||
A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model | Critical Reviews in Therapeutic Drug Carrier Systems | 1997 | 364 | 0 | |||
Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-co-glycolide) microspheres prepared by a W/O/W solvent evaporation method | Pharmaceutical Research | 1996 | 300 | 0 | |||
Oral administration of peptides: Study of a glycerolipidic prodrug | International Journal of Pharmaceutics | 1995 | 309 | 0 | |||
Characterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (w1/o)w2 emulsion solvent evaporation method | International Journal of Pharmaceutics | 1994 | 378 | 0 | |||
Synthesis and in vitro study of a diglyceride prodrug of a peptide | Pharmaceutical Research | 1994 | 325 | 0 |